Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vaccinex Inc
(NQ:
VCNX
)
5.380
+0.250 (+4.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Vaccinex Inc
< Previous
1
2
Next >
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Shares of Vaccinex, Inc. are higher on February 7 on news that the clinical-stage biotechnology company secured a patent. Is it time to buy or sell the news?
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
January 09, 2023
Surface Oncology initiates clinical trial with antibody discovered using Vaccinex’s ActivMAb® Antibody Discovery Platform
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Announces $3.8 Million Private Placement
November 28, 2022
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Third Quarter 2022 Results and Provides Corporate Update
November 14, 2022
Continued Progress in Pepinemab Oncology and Neurology Clinical Programs
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex and its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of Cancer
November 10, 2022
New Biomarkers of Response and Resistance that Suggest Pepinemab Could Offer New Combination Treatment Options
From
Vaccinex, Inc.
Via
GlobeNewswire
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
January 27, 2022
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,...
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.